T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response
Class IA phosphatidylinositol 3-kinase (PI3K) catalytic subunits p110? and p110? are targets in cancer therapy expressed at high levels in T lymphocytes. The role of p110? PI3K in normal or pathological immune responses is well established, yet the importance of p110? subunits in T cell-dependent im...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2018
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/25984
- Acceso en línea:
- https://doi.org/10.3389/fimmu.2018.00332
https://repository.urosario.edu.co/handle/10336/25984
- Palabra clave:
- PI3K
PI3-kinase alpha subunit
T lymphocytes
CD28 costimulation
Anti-KLH response
Melanoma
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_556b10edd96ad9c78e7b35fb98c8dbe1 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/25984 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
d21e5897-03b2-4268-b7c0-769ad1e7fccf6a90ad22-047b-4f80-9630-ae6a35c83bcb7cf6c875-8bf1-4751-8513-455dd938902f383619336003dda9eae-52e7-4e1b-8cbd-d5e0c042e77cf4206ca1-090f-4d04-8020-736877234c7ea68111d5-fdd7-412d-a871-4f65406203602020-08-06T16:20:23Z2020-08-06T16:20:23Z2018-02-27Class IA phosphatidylinositol 3-kinase (PI3K) catalytic subunits p110? and p110? are targets in cancer therapy expressed at high levels in T lymphocytes. The role of p110? PI3K in normal or pathological immune responses is well established, yet the importance of p110? subunits in T cell-dependent immune responses is not clear. To address this problem, mice with p110? conditionally deleted in CD4+ and CD8+ T lymphocytes (p110??/??T) were used. p110??/??T mice show normal development of T cell subsets, but slightly reduced numbers of CD4+ T cells in the spleen. “In vitro,” TCR/CD3 plus CD28 activation of naive CD4+ and CD8+ p110??/??T T cells showed enhanced effector function, particularly IFN-? secretion, T-bet induction, and Akt, Erk, or P38 activation. Tfh derived from p110??/??T cells also have enhanced responses when compared to normal mice, and IL-2 expanded p110??/??T CD8+ T cells had enhanced levels of LAMP-1 and Granzyme B. By contrast, the expansion of p110??/??T iTreg cells was diminished. Also, p110??/??T mice had enhanced anti-keyhole limpet hemocyanin (KLH) IFN-?, or IL-4 responses and IgG1 and IgG2b anti-KLH antibodies, using CFA or Alum as adjuvant, respectively. When compared to WT mice, p110??/??T mice inoculated with B16.F10 melanoma showed delayed tumor progression. The percentage of CD8+ T lymphocytes was higher and the percentage of Treg cells lower in the spleen of tumor-bearing p110??/??T mice. Also, IFN-? production in tumor antigen-activated spleen cells was enhanced. Thus, PI3K p110? plays a significant role in antigen activation and differentiation of CD4+ and CD8+ T lymphocytes modulating antitumor immunity.application/pdfhttps://doi.org/10.3389/fimmu.2018.00332EISSN: 1664-3224https://repository.urosario.edu.co/handle/10336/25984engFrontiers Social MediaFrontiers in ImmunologyVol. 9Frontiers in Immunology, EISSN: 1664-3224, Vol.9 (February 2018); 14 pp.https://www.frontiersin.org/articles/10.3389/fimmu.2018.00332/fullAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Frontiers in Immunologyinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPI3KPI3-kinase alpha subunitT lymphocytesCD28 costimulationAnti-KLH responseMelanomaT-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor responseLa pérdida específica de células T de la subunidad catalítica p110? de PI-3-linasa da como resultado una producción mejorada de citocinas y una respuesta antitumoralarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Aragoneses-Fenoll, LauraOjeda, GloriaMontes-Casado, MaríaAcosta Ampudia, Yeny YasbleidyDianzani, UmbertoPortolés, PilarRojo, José M.ORIGINALfimmu-09-00332.pdfapplication/pdf4295808https://repository.urosario.edu.co/bitstreams/9b4cd4d9-2fcc-49e4-8a6f-636829e3e442/downloada3ba0a439dea6810f4f36409d050248eMD51TEXTfimmu-09-00332.pdf.txtfimmu-09-00332.pdf.txtExtracted texttext/plain58540https://repository.urosario.edu.co/bitstreams/374c1709-d3f6-4bb6-8596-12d7f287b126/download6218098006187ca862e18e5645db87e0MD52THUMBNAILfimmu-09-00332.pdf.jpgfimmu-09-00332.pdf.jpgGenerated Thumbnailimage/jpeg4521https://repository.urosario.edu.co/bitstreams/819cce42-9972-4ef4-95c3-3cd932aafccf/downloadec14b91dbb1cad9bd4717fba15c8ed45MD5310336/25984oai:repository.urosario.edu.co:10336/259842021-08-04 11:47:14.211https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response |
dc.title.TranslatedTitle.spa.fl_str_mv |
La pérdida específica de células T de la subunidad catalítica p110? de PI-3-linasa da como resultado una producción mejorada de citocinas y una respuesta antitumoral |
title |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response |
spellingShingle |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response PI3K PI3-kinase alpha subunit T lymphocytes CD28 costimulation Anti-KLH response Melanoma |
title_short |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response |
title_full |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response |
title_fullStr |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response |
title_full_unstemmed |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response |
title_sort |
T-Cell-specific loss of the PI-3-linase p110? catalytic subunit results in enhanced cytokine production and antitumor response |
dc.subject.keyword.spa.fl_str_mv |
PI3K PI3-kinase alpha subunit T lymphocytes CD28 costimulation Anti-KLH response Melanoma |
topic |
PI3K PI3-kinase alpha subunit T lymphocytes CD28 costimulation Anti-KLH response Melanoma |
description |
Class IA phosphatidylinositol 3-kinase (PI3K) catalytic subunits p110? and p110? are targets in cancer therapy expressed at high levels in T lymphocytes. The role of p110? PI3K in normal or pathological immune responses is well established, yet the importance of p110? subunits in T cell-dependent immune responses is not clear. To address this problem, mice with p110? conditionally deleted in CD4+ and CD8+ T lymphocytes (p110??/??T) were used. p110??/??T mice show normal development of T cell subsets, but slightly reduced numbers of CD4+ T cells in the spleen. “In vitro,” TCR/CD3 plus CD28 activation of naive CD4+ and CD8+ p110??/??T T cells showed enhanced effector function, particularly IFN-? secretion, T-bet induction, and Akt, Erk, or P38 activation. Tfh derived from p110??/??T cells also have enhanced responses when compared to normal mice, and IL-2 expanded p110??/??T CD8+ T cells had enhanced levels of LAMP-1 and Granzyme B. By contrast, the expansion of p110??/??T iTreg cells was diminished. Also, p110??/??T mice had enhanced anti-keyhole limpet hemocyanin (KLH) IFN-?, or IL-4 responses and IgG1 and IgG2b anti-KLH antibodies, using CFA or Alum as adjuvant, respectively. When compared to WT mice, p110??/??T mice inoculated with B16.F10 melanoma showed delayed tumor progression. The percentage of CD8+ T lymphocytes was higher and the percentage of Treg cells lower in the spleen of tumor-bearing p110??/??T mice. Also, IFN-? production in tumor antigen-activated spleen cells was enhanced. Thus, PI3K p110? plays a significant role in antigen activation and differentiation of CD4+ and CD8+ T lymphocytes modulating antitumor immunity. |
publishDate |
2018 |
dc.date.created.spa.fl_str_mv |
2018-02-27 |
dc.date.accessioned.none.fl_str_mv |
2020-08-06T16:20:23Z |
dc.date.available.none.fl_str_mv |
2020-08-06T16:20:23Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.3389/fimmu.2018.00332 |
dc.identifier.issn.none.fl_str_mv |
EISSN: 1664-3224 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/25984 |
url |
https://doi.org/10.3389/fimmu.2018.00332 https://repository.urosario.edu.co/handle/10336/25984 |
identifier_str_mv |
EISSN: 1664-3224 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationTitle.none.fl_str_mv |
Frontiers in Immunology |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 9 |
dc.relation.ispartof.spa.fl_str_mv |
Frontiers in Immunology, EISSN: 1664-3224, Vol.9 (February 2018); 14 pp. |
dc.relation.uri.spa.fl_str_mv |
https://www.frontiersin.org/articles/10.3389/fimmu.2018.00332/full |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Frontiers Social Media |
dc.source.spa.fl_str_mv |
Frontiers in Immunology |
institution |
Universidad del Rosario |
dc.source.instname.none.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.none.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
bitstream.url.fl_str_mv |
https://repository.urosario.edu.co/bitstreams/9b4cd4d9-2fcc-49e4-8a6f-636829e3e442/download https://repository.urosario.edu.co/bitstreams/374c1709-d3f6-4bb6-8596-12d7f287b126/download https://repository.urosario.edu.co/bitstreams/819cce42-9972-4ef4-95c3-3cd932aafccf/download |
bitstream.checksum.fl_str_mv |
a3ba0a439dea6810f4f36409d050248e 6218098006187ca862e18e5645db87e0 ec14b91dbb1cad9bd4717fba15c8ed45 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167541208055808 |